Premier Alternatives

Nusano

Santa Clarita, CA · Founded 2016 · Privately Held (backing)

Developer of a current ion source and linear accelerator intended to remove the current limitations of radioisotope manufacturing for medical applications and innovation. Nusano is based in Santa Clarita, CA and was founded in 2016. It was valued at $265 million at its later-stage round in Oct 2024, the last priced event on record. It has raised $218 million across 2 recorded rounds; the latest was a $10 million early-stage round in Nov 2022.

PMV mark · valuation
$265.0M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$217.7M
Last round
Early Stage VC
Nov 2022

Nusano key facts

as of Oct 2026
  • Developer of a current ion source and linear accelerator intended to remove the current limitations of radioisotope manufacturing for medical applications and innovation.
  • Nusano is valued at approximately $265.0M as of Oct 2026, set at its later-stage round, Oct 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $217.7M across 2 recorded rounds; the latest was Early Stage VC ($10.0M) in Nov 2022.
  • Notable investors include S32, Casdin Capital, Verily Life Sciences, Wasatch Equity Partners, ACS BrightEdge — 8 tracked in total.
  • Nusano has filed 2 Form Ds with the SEC since 2021, most recently Nov 2022 ($10.0M sold to 1 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$265.0M

Valued at $265.0M at its later-stage round, Oct 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Nusano with a free account
  • ·Watch Nusano: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Nusano funding rounds

2 rounds
Nov 2022Early Stage VC$10.0MSEC filing▮
Sep 2021Early Stage VC$48.0MSEC filing▮
Full funding history →

Nusano valuation

Nusano was valued at $265 million at its later-stage round in Oct 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Nusano raised?

Nusano has raised $218 million in total; 2 of its rounds are on record. The largest on record was a $48 million early-stage round in Sep 2021; the most recent was a $10 million early-stage round in Nov 2022.

Nusano has filed 2 Form Ds with the SEC since 2021, most recently in Nov 2022 ($10 million sold to 1 investor).

Nusano investors

8 investors are on record for Nusano, including S32, Casdin Capital, Verily Life Sciences and Wasatch Equity Partners. The early-stage round in Nov 2022 drew 1 investor.

About Nusano

Developer of a current ion source and linear accelerator intended to remove the current limitations of radioisotope manufacturing for medical applications and innovation. The company offers a broad range of diagnostic and therapeutic radioisotopes, which are produced uranium-free, helping healthcare sector clients develop radiopharmaceuticals for personalized cancer therapies at comparatively lower costs.

Sector
Healthcare
HQ
Santa Clarita, CA, United States
Founded
2016
Employees
175
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.